Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Cell Cycle (Georgetown, Tex.)|October 12, 2020
miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancerHui Yang, Jian Lin, Jinling Jiang, et al.
Oncology Research|January 22, 2017
3-Phosphoinositide Dependent Protein Kinase-1 (PDK-1) Promotes Migration and Invasion in Gastric Cancer Cells Through Activating the NF-κB PathwayNing Wu, Changyu He, Bohui Zhu, et al.
Oncology Letters|January 19, 2018
Metronomic chemotherapy remodel cancer-associated fibroblasts to decrease chemoresistance of gastric cancer in nude miceChao Wang, Wenqi Xi, Jinling Jiang, et al.
Scientific Reports|June 8, 2017
PKM2 promotes cell migration and inhibits autophagy by mediating PI3K/AKT activation and contributes to the malignant development of gastric cancerChao Wang, Jinling Jiang, Jun Ji, et al.
Theranostics|November 8, 2019
A self-enforcing HOXA11/Stat3 feedback loop promotes stemness properties and peritoneal metastasis in gastric cancer cellsChao Wang, Min Shi, Jun Ji, et al.
Cell Death & Disease|June 9, 2023
HNF4A-BAP31-VDAC1 axis synchronously regulates cell proliferation and ferroptosis in gastric cancerQingqing Zhou, Tengfei Liu, Wenjing Qian, et al.
Oncogene|November 21, 2023
Tumor-mesothelium HOXA11-PDGF BB/TGF β1-miR-181a-5p-Egr1 feedforward amplifier circuity propels mesothelial fibrosis and peritoneal metastasis of gastric cancerChao Wang, Jun Ji, Yangbing Jin, et al.
Frontiers in Oncology|July 1, 2021
A Novel Inflammatory-Nutritional Prognostic Scoring System for Stage III Gastric Cancer Patients With Radical Gastrectomy Followed by Adjuvant ChemotherapyNan Wang, Wenqi Xi, Sheng Lu, et al.
Molecular and Clinical Oncology|November 29, 2017
Comprehensive treatment of unresectable cardiac angiosarcoma: A case report and review of literatureChao Wang, Min Shi, Chen Yang, et al.
Cancer Management and Research|October 3, 2019
Pre-treatment inflammatory biomarkers predict early treatment response and favorable survival in patients with metastatic colorectal cancer who underwent first line cetuximab plus chemotherapyJinling Jiang, Tao Ma, Wenqi Xi, et al.
Pageof 5